Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Needham & Company LLC 

Personalis Inc diskutieren

Personalis Inc

WKN: A2PLTK / Symbol: PSNL / Name: Personalis / Aktie / Biotechnologie & medizinische Forschung / ? /

4,67 €
-0,26 %

Einschätzung Buy
Rendite (%) 62,25 %
Kursziel 6,35
Veränderung
Endet am 10.08.24

Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $7.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 313,09 %
Kursziel 2,15
Veränderung
Endet am 08.11.24

Personalis, Inc. (NASDAQ: PSNL) had its price target lowered by analysts at Needham & Company LLC from $7.00 to $2.30. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 154,60 %
Kursziel 2,10
Veränderung
Endet am 05.01.25

Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.30 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 218,04 %
Kursziel 3,23
Veränderung
Endet am 28.02.25

Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at Needham & Company LLC from $2.30 to $3.50. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 270,79 %
Kursziel 3,26
Veränderung
Endet am 11.04.25

Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 240,28 %
Kursziel 3,74
Veränderung
Endet am 30.04.25

Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 198,20 %
Kursziel 3,25
Veränderung
Endet am 09.05.25

Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) 305,98 %
Kursziel 3,27
Veränderung
Endet am 21.06.25

Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) -14,04 %
Kursziel 6,58
Veränderung
Endet am 16.08.25

Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at Needham & Company LLC from $5.50 to $7.25. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,43 %
Kursziel 6,35
Veränderung
Endet am 16.08.25

Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at BTIG Research from $5.50 to $7.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat

Einschätzung Buy
Rendite (%) -16,27 %
Kursziel 8,15
Veränderung
Endet am 19.08.25

Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at HC Wainwright from $7.50 to $9.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat